Intradermal Vaccination with PLGA Nanoparticles via Dissolving Microneedles and Classical Injection Needles
Pharmaceutical Research · 2024
DOI: 10.1007/s11095-024-03665-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, 2024. Verfasst von Jihui Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Vaccination, Nanoparticles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Purpose
A dissolving microneedle array (dMNA) is a vaccine delivery device with several advantages over conventional needles. By incorporating particulate adjuvants in the form of poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) into the dMNA, the immune response against the antigen might be enhanced. This study aimed to prepare PLGA-NP-loaded dMNA and to compare T-cell responses induced by either intradermally injected aqueous-PLGA-NP formulation or PLGA-NP-loaded dMNA in mice.
Methods
PLGA NPs were prepared with microfluidics, and their physicochemical characteristics with regard to encapsulation efficiencies of ovalbumin (OVA) and CpG oligonucleotide (CpG), zeta potentials, polydispersity indexes, and sizes were analysed. PLGA NPs incorporated dMNA was produced with three different dMNA formulations by using the centrifugation method, and the integrity of PLGA NPs in dMNAs was evaluated. The immunogenicity was evaluated in mice by comparing the T-cell responses induced by dMNA and aqueous formulations containing ovalbumin and CpG (OVA/CpG) with and without PLGA NP.
Results
Prepared PLGA NPs had a size of around 100 nm. The dMNA formulations affected the particle integrity, and the dMNA with poly(vinyl alcohol) (PVA) showed almost no aggregation of PLGA NPs. The PLGA:PVA weight ratio of 1:9 resulted in 100% of penetration efficiency and the fastest dissolution in ex-vivo human skin (< 30 min). The aqueous formulation with soluble OVA/CpG and the aqueous-PLGA-NP formulation with OVA/CpG induced the highest CD4 + T-cell responses in blood and spleen cells.
Conclusions
PLGA NPs incorporated dMNA was successfully fabricated and the aqueous formulation containing PLGA NPs induce superior CD4 + and CD8 + T-cell responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, the Netherlands.
- Tyndall National Institute, Lee Maltings, Prospect Row, Cork, Ireland.
- Division of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333CC, Leiden, the Netherlands. K.van_der_Maaden@lumc.nl.
- Department of Immunology, Leiden University Medical Center, 2300RC, Leiden, the Netherlands. K.van_der_Maaden@lumc.nl.
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Lee, J., Neustrup, M. A., Slütter, B., O'Mahony, C., Bouwstra, J. A., & van der Maaden, K. (2024). Intradermal Vaccination with PLGA Nanoparticles via Dissolving Microneedles and Classical Injection Needles. Pharmaceutical Research. https://doi.org/10.1007/s11095-024-03665-7
Vancouver
Lee J, Neustrup MA, Slütter B, O'Mahony C, Bouwstra JA, van der Maaden K. Intradermal Vaccination with PLGA Nanoparticles via Dissolving Microneedles and Classical Injection Needles. Pharmaceutical Research. 2024. doi:10.1007/s11095-024-03665-7
BibTeX
@article{Lee2024,
author = {Lee, Jihui and Neustrup, Malene A and Slütter, Bram and O'Mahony, Conor and Bouwstra, Joke A and van der Maaden, Koen},
title = {Intradermal Vaccination with PLGA Nanoparticles via Dissolving Microneedles and Classical Injection Needles},
journal = {Pharmaceutical Research},
year = {2024},
doi = {10.1007/s11095-024-03665-7}
}
EUVIMED